BOSTON, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (PRAX) (NASDAQ: PRAX), a clinical-stage biopharmaceutical company focused on developing therapies for central nervous system ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results